We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-5.15%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$242M
AUM Growth
-$27.8M
Cap. Flow
-$11.1M
Cap. Flow %
-4.59%
Top 10 Hldgs %
37.51%
Holding
109
New
14
Increased
27
Reduced
32
Closed
36

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$7.67M
2
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$5.23M
3
PFE icon
Pfizer
PFE
+$4.48M
4
EVHC
Envision Healthcare Holdings Inc
EVHC
+$3.65M
5
GSK icon
GSK
GSK
+$3.41M

Top Sells

Rank Stock Value
1
AMSG
Amsurg Corp
AMSG
+$9.89M
2
AET
Aetna Inc
AET
+$5.01M
3
AGN
Allergan plc
AGN
+$4.99M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.37M
5
VWR
VWR Corporation
VWR
+$3.05M

Sector Composition

Rank Sector Weight
1 Healthcare 87.52%
2 Financials 2.14%
3 Energy 0%
4 Industrials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKD icon
76
Brookdale Senior Living
BKD
$3.49B
– –
-59,070
Closed -$1.03M
CHRS icon
77
Coherus Oncology
CHRS
$217M
– –
-8,400
Closed -$225K
CNMD icon
78
CONMED
CNMD
$1.39B
– –
-39,500
Closed -$1.58M
GILD icon
79
Gilead Sciences
GILD
$162B
– –
-20,810
Closed -$1.65M
ILMN icon
80
Illumina
ILMN
$31B
– –
-3,567
Closed -$630K
MRK icon
81
Merck
MRK
$322B
– –
-5,345
Closed -$318K
PCRX icon
82
Pacira BioSciences
PCRX
$1.04B
– –
-10,500
Closed -$359K
PRGO icon
83
Perrigo
PRGO
$1.4B
– –
-15,100
Closed -$1.39M
RGNX icon
84
Regenxbio
RGNX
$620M
– –
-12,026
Closed -$168K
RIGL icon
85
Rigel Pharmaceuticals
RIGL
$681M
– –
-8,444
Closed -$310K
TNDM icon
86
Tandem Diabetes Care
TNDM
$1.34B
– –
-9,481
Closed -$726K
UHS icon
87
Universal Health Services
UHS
$10.2B
– –
-6,657
Closed -$820K
VRTX icon
88
Vertex Pharmaceuticals
VRTX
$121B
– –
-5,150
Closed -$449K
XRAY icon
89
Dentsply Sirona
XRAY
$2.68B
– –
-18,900
Closed -$1.12M
LUMO
90
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-3,310
Closed -$447K
ALPN
91
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-21,353
Closed -$694K
NSTG
92
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-69,574
Closed -$1.39M
RAD
93
DELISTED
Rite Aid Corporation
RAD
– –
-885
Closed -$136K
ALR
94
DELISTED
AlerisLife Inc
ALR
– –
-57,508
Closed -$1.1M
LHCG
95
DELISTED
LHC Group LLC
LHCG
– –
-42,700
Closed -$1.57M
RDUS
96
DELISTED
Radius Health, Inc.
RDUS
– –
-6,300
Closed -$341K
CSLT
97
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
– –
-184,826
Closed -$769K
TRIL
98
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-24,400
Closed -$361K
AMAG
99
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-114,980
Closed -$2.82M
ALDR
100
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-19,500
Closed -$639K
1 2 3
4
5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Endurant Capital Management held 109 positions worth $242M, down 10% from $270M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Endurant Capital Management withdrew a net $11.1M in Q4 2016, closing 36 positions and reducing 32 holdings. Its most notable exit was Amsurg Corp, an estimated $9.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Financials and Energy.

Against the trend, Endurant Capital Management opened a new position in Pfizer worth $4.52M.

  • Endurant Capital Management's largest Q4 2016 buy was Pfizer: 146,611 shares worth $4.52M.
  • Endurant Capital Management added most to Becton Dickinson in Q4 2016, an estimated $7.67M increase.
  • Endurant Capital Management's biggest Q4 2016 reduction was Aetna Inc, cutting an estimated $5.01M.
  • Endurant Capital Management fully exited Amsurg Corp in Q4 2016, selling an estimated $9.89M.
  • Endurant Capital Management's ten largest holdings make up 38% of its $242M portfolio in Q4 2016.
  • Endurant Capital Management opened 14 new positions and closed 36 in Q4 2016.
  • Endurant Capital Management's portfolio value fell 10% quarter-over-quarter to $242M.

Based on Endurant Capital Management's 13F filing for Q4 2016, filed 15 Feb 2017.